Back
About the Global Fund
Results Report 2021
-
Programs supported by the Global Fund partnership had saved 44 million lives as of the end of 2020. But over the last year, the impact of the COVID-19 pandemic has been devastating.
- Read the online report
People & Structures
Back
Funding Model
Investments & Results
Explore contributions, investments and results in our fight against AIDS, tuberculosis and malaria around the world.
Back
News
-
11 November 2021
United States to Host Next Global Fund Replenishment Conference -
11 November 2021
Lifeline Support from UNDP and the Global Fund Keeps Afghanistan’s Health Facilities Open -
10 November 2021
Global Fund Board Approves New Strategy Placing People and Communities at Center to Lead Fight Against HIV, TB, Malaria, to Build Systems for Health, Equity and Strengthen Pandemic Preparedness
Updates
Stories
Back
Featured Publication
Documents by type
Sourcing & Management
Opportunity for Evaluation of Selected Medicines
27 September 2021
The Global Fund, Stop TB Partnership Global Drug Facility and Unitaid are inviting manufacturers of Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial medicines to submit an expression of interest to have their products evaluated by the Expert Review Panel for Pharmaceutical Products.
Detailed information about the review process and submission requirements for this Round 24 opportunity can be found in the document below.
Once all expressions of interest have been received, the Expert Review Panel will be responsible for reviewing and judging their eligibility and whether to perform a risk-benefit assessment of the products submitted.
The deadline for submission of an expression of interest is Friday, 19th November 2021 (COB). End of November 2021, the Global Fund Secretariat will communicate to manufacturers the outcomes of the review of the completeness of the documents submitted. The results of the product evaluations are expected to be released End of January 2022.
- Invitation to Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial Medicines Manufacturers to Submit an Expression of Interest for Product Evaluation by the Global Fund Expert Review Panel for Pharmaceutical Products
download in English
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.